Search
Patexia Research
Case number 1:20-cv-00761

Sanofi-Aventis U.S. LLC et al v. Mylan Laboratories Limited > Documents

Date Field Doc. No.Description (Pages)
Sep 8, 2021 23 Order (2)
Sep 8, 2021 23 Main Document (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,583,110 B2; 10,716,777 B2. (Attachments: # (1) Order)(nms)
Sep 8, 2021 N/A Terminated Case (0)
Docket Text: CASE CLOSED per entry of D.I. 251 in Lead Civil Action 20cv804-RGA. (nms)
Sep 7, 2021 N/A CORRECTING ENTRY: (0)
Docket Text: CORRECTING ENTRY: The stipulation filed at D.I. 23 has been removed from the docket. All filings are to be made in Lead Civil Action 20-804-RGA only (see D.I. [20]). (nms)
Oct 30, 2020 22 Order Setting Teleconference (4)
Docket Text: ORDER Setting Teleconference: A Telephone Conference is set for 12/11/2020 at 10:30 AM Eastern Time with Judge Mary Pat Thynge to discuss ADR. Plaintiffs' counsel to initiate the call. Signed by Judge Mary Pat Thynge on 10/30/20. Associated Cases: 1:20-cv-00761-RGA, 1:20-cv-00804-RGA(cak)
Aug 5, 2020 N/A Oral Order (0)
Docket Text: ORAL ORDER: The Rule 16(b) Conference set for 8/7/2020, is CANCELED. Ordered by Judge Richard G. Andrews on 8/5/2020. Associated Cases: 1:20-cv-00646-RGA, 1:20-cv-00761-RGA, 1:20-cv-00803-RGA, 1:20-cv-00804-RGA(nms)
Aug 5, 2020 20 Scheduling Order (11)
Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Case referred to a Magistrate Judge to handle all discovery disputes including any that arise in connection with expert reports. These actions are consolidated for all purposes and all papers shall be filed in Civil Action No. 20-804-RGA. Joinder of Parties due by 12/11/2020. Amended Pleadings due by 12/11/2020. Discovery due by 12/18/2020. Joint Claim Construction Brief due by 11/25/2020. A Markman Hearing is set for 12/17/2020, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 5/14/2021, at 9:00 AM in Courtroom 6A. A 3 day ench Trial is set to start 5/24/2021, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 8/5/2020. Associated Cases: 1:20-cv-00646-RGA, 1:20-cv-00761-RGA, 1:20-cv-00803-RGA, 1:20-cv-00804-RGA(nms) Modified on 8/5/2020 (nms).
Aug 5, 2020 19 Letter to the Honorable Richard G. Andrews (1)
Aug 5, 2020 19 Main Document (11)
Docket Text: PROPOSED Scheduling Order, by Sanofi Mature IP, Sanofi-Aventis U.S. LLC. (Attachments: # (1) Letter)(Blumenfeld, Jack) Modified on 8/5/2020 (nms).
Aug 5, 2020 N/A Case Referred to Mediation (0)
Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf Associated Cases: 1:20-cv-00761-RGA, 1:20-cv-00803-RGA, 1:20-cv-00804-RGA(cak)
Aug 4, 2020 18 Letter (1)
Docket Text: Letter to The Honorable Richard G. Andrews from Jack B. Blumenfeld regarding dial-in information for the August 7, 2020 scheduling teleconference. (Blumenfeld, Jack)
Jul 31, 2020 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorneys William E. Solander and Daniel J. Minion for Sanofi Mature IP and Sanofi-Aventis U.S. LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-00646-RGA, 1:20-cv-00761-RGA, 1:20-cv-00803-RGA, 1:20-cv-00804-RGA(kmd)
Jul 22, 2020 16 Amended Complaint* (1)
Jul 22, 2020 17 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,716,777 . (Blumenfeld, Jack)
Jul 22, 2020 16 Exhibits A-C (87)
Jul 22, 2020 16 Main Document (19)
Docket Text: First AMENDED COMPLAINT against Mylan Laboratories Limited- filed by Sanofi-Aventis U.S. LLC, Sanofi Mature IP. (Attachments: # (1) Exhibits A-C)(Blumenfeld, Jack)
Jul 6, 2020 15 Order Setting Scheduling Conference (1)
Docket Text: Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 8/7/2020, at 10:00 AM in Chambers before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 7/6/2020. (nms)
Jul 2, 2020 14 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mylan Inc. for Mylan Laboratories Limited filed by Mylan Laboratories Limited. (Moore, David)
Jul 2, 2020 13 Answer to Complaint (21)
Docket Text: ANSWER to [1] Complaint, Separate Defenses, and COUNTERCLAIMS against Sanofi Mature IP, Sanofi-Aventis U.S. LLC by Mylan Laboratories Limited.(Moore, David) Modified on 7/6/2020 (nms).
Jul 1, 2020 12 Letter (4)
Docket Text: Letter to The Honorable Richard G. Andrews, from David E. Moore, Esq., regarding request for an early Rule 16 conference. (Moore, David) Modified on 7/2/2020 (nms).
Jun 30, 2020 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Michael S. Scerbo for Sanofi Mature IP and Sanofi-Aventis U.S. LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-00646-RGA, 1:20-cv-00761-RGA, 1:20-cv-00803-RGA, 1:20-cv-00804-RGA(mal)
Jun 29, 2020 11 Letter (2)
Docket Text: Letter to The Honorable Richard G. Andrews from Jack B. Blumenfeld regarding request for an early Rule 16 conference. (Blumenfeld, Jack)
Jun 25, 2020 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (10 in 20-cv-761-RGA; 11 in 20-cv-46-RGA; 9 in 20-cv-803-RGA; 24 in 20-cv-804-RGA) MOTION for Pro Hac Vice Appearance of Attorney Jiang Lin, filed by Sanofi Mature IP, Sanofi-Aventis U.S. LLC. Signed by Judge Richard G. Andrews on 6/25/2020. Associated Cases: 1:20-cv-00646-RGA, 1:20-cv-00761-RGA, 1:20-cv-00803-RGA, 1:20-cv-00804-RGA(nms)
Jun 25, 2020 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Whitney L. Meier for Sanofi Mature IP, for Sanofi-Aventis U.S. LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr)
Jun 24, 2020 10 Motion for Leave to Appear Pro Hac Vice (6)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jiang Lin - filed by Sanofi Mature IP, Sanofi-Aventis U.S. LLC. (Fahnestock, Derek)
Jun 24, 2020 9 Motion for Leave to Appear Pro Hac Vice (9)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney William E. Solander, Daniel J. Minion, Whitney L. Meier and Michael S. Scerbo - filed by Sanofi Mature IP, Sanofi-Aventis U.S. LLC. (Fahnestock, Derek)
Jun 24, 2020 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (9 in 20-cv-761-RGA; 8 in 20-cv-803-RGA; 10 in 20-cv-646-RGA; 23 in 20-cv-804-RGA) MOTION for Pro Hac Vice Appearance of Attorney William E. Solander, Daniel J. Minion, Whitney L. Meier and Michael S. Scerbo, filed by Sanofi Mature IP, Sanofi-Aventis U.S. LLC. Signed by Judge Richard G. Andrews on 6/24/2020. Associated Cases: 1:20-cv-00646-RGA, 1:20-cv-00761-RGA, 1:20-cv-00803-RGA, 1:20-cv-00804-RGA(nms)
Jun 24, 2020 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Kristina M. Hanson for Mylan Laboratories Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr)
Jun 24, 2020 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Edward Powell, III for Mylan Laboratories Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr)
Jun 23, 2020 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Wendy L. Devine for Mylan Laboratories Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr)
Jun 23, 2020 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Matthew R. Reed for Mylan Laboratories Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr)
Jun 19, 2020 8 Motion for Leave to Appear Pro Hac Vice (6)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Wendy Lynn Devine, Kristina M. Hanson, Matthew R. Reed, and G. Edward Powell, III of Wilson Sonsini Goodrich and Rosati - filed by Mylan Laboratories Limited. (Palapura, Bindu)
Jun 19, 2020 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [8] MOTION for Pro Hac Vice Appearance of Attorney Wendy Lynn Devine, Kristina M. Hanson, Matthew R. Reed, and G. Edward Powell, III of Wilson Sonsini Goodrich and Rosati, filed by Mylan Laboratories Limited. Signed by Judge Richard G. Andrews on 6/19/2020. (nms)
Jun 11, 2020 7 Affidavit of Service (9)
Docket Text: AFFIDAVIT of Service for Summons, Complaint and Related Papers served on Mylan Laboratories Limited on June 11, 2020, filed by Sanofi Mature IP, Sanofi-Aventis U.S. LLC. (Blumenfeld, Jack)
Jun 10, 2020 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)
Jun 8, 2020 6 Summons Issued - Electronic (2)
Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (mal)
Jun 5, 2020 5 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sanofi for Sanofi Mature IP, and Sanofi-Aventis U.S. LLC filed by Sanofi Mature IP, Sanofi-Aventis U.S. LLC. (mal)
Jun 5, 2020 4 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,583,110 B2. (mal)
Jun 5, 2020 3 ANDA Form (1)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: May 29, 2020. Date of Expiration of Patent: October 27, 2030. Thirty Month Stay Deadline: Not Applicable. (mal)
Jun 5, 2020 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal)
Jun 5, 2020 1 Civil Cover Sheet (1)
Jun 5, 2020 1 Exhibit A-B (58)
Jun 5, 2020 1 Complaint* (1)
Jun 5, 2020 1 Main Document (12)
Docket Text: COMPLAINT for Patent Infringement filed against Mylan Laboratories Limited (Filing fee $ 400, receipt number ADEDC-2976604) - filed by Sanofi-Aventis U.S. LLC, Sanofi Mature IP. (Attachments: # (1) Exhibits A-B, # (2) Civil Cover Sheet)(mal) Modified on 6/11/2020 (nms).
Menu